Company intelligence
deepmirror
The foundation model for drug design
About deepmirror
deepmirror is building the foundation model for drug design. AI for drug design is limited by sparse and fragmented data, but our AI-native infrastructure empowers chemistry teams to better harness their data to progress programs faster, with fewer dead ends. With each project, the data sets grow and the model improves, generating even greater outcomes. We are based in London and already trusted by 100+ organisations across the globe. For more information, visit http://deepmirror.ai
Verified activity
Signals from deepmirror
8 published signals
Products & Services
deepmirror updated its website and app to reflect its stellar ambitions and new look
Reported by deepmirror
Research & Knowledge
deepmirror saw a perspective on benchmark to clinical impact from A Nature Reviews Drug Discovery.
Reported by deepmirror
Products & Services
deepmirror saw OpenADMET open a community blind challenge on CYP inhibition.
Reported by deepmirror
Products & Services
deepmirror launched additional product updates for its AI-powered drug hunting product.
Reported by deepmirror
Products & Services
deepmirror launched a redesigned side navigation for its AI-powered drug hunting product updates.
Reported by deepmirror
Products & Services
deepmirror launched a ligand strain calculated for every alignment for its AI-powered drug hunting product updates.
Reported by deepmirror
Partnerships
deepmirror saw Novo Nordisk name AWS its preferred cloud and AI partner.
Reported by deepmirror
Partnerships
deepmirror saw Bristol Myers Squibb pick up Chai Discovery's folding and design models for antibody discovery.
Reported by deepmirror